BVT Aktienanleihe NSRGF 28.03.202.../ DE000VD2UAT3 /
08/11/2024 19:54:27 | Var.-0.290 | Denaro21:59:54 | Lettera21:59:54 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
96.700EUR | -0.30% | - Quantità in denaro: - |
- Quantità in lettera: - |
Nestle S.A. | 80.00 - | 28/03/2025 | Call |
GlobeNewswire
13/08
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
06/08
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
23/07
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
12/06
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06/06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
08/05
WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
26/03
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
19/03
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...